Floatz logo

Semaglutide

Idiopathic Intracranial Hypertension

Rigmor Højland Jensenprotein_peptidePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Idiopathic Intracranial Hypertension cohort.

Asset / SponsorPhaseRating
Acetazolamide
St. Luke's-Roosevelt Hospital Center
Phase 2/3B
azd4017
University of Birmingham
Phase 2B

Same molecule, other indications

Semaglutide is also rated in:

metabolic diseaseDormant
A
Indicative ·
81 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →